{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:12:50Z","timestamp":1761919970671},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.3660","type":"journal-article","created":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T18:05:18Z","timestamp":1430417118000},"page":"1105-1107","source":"Crossref","is-referenced-by-count":3,"title":["Human T-lymphotropic Virus Type-I (HTLV-I)-associated Myelopathy with Bulbar Palsy-type Amyotrophic Lateral Sclerosis-like Symptoms"],"prefix":"10.2169","volume":"54","author":[{"given":"Rina","family":"Ando","sequence":"first","affiliation":[{"name":"Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Tsujii","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Iwaki","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Yabe","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nomoto","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1: 1031-1032, 1986.","DOI":"10.1016\/S0140-6736(86)91298-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nomoto M, Utatsu Y, Soejima Y, Osame M. Neopterin in cerebrospinal fluid: a useful marker for diagnosis of HTLV-I-associated myelopathy\/tropical spastic paraparesis. Neurology 41: 457, 1991.","DOI":"10.1212\/WNL.41.3.457"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol 4: 586-593, 1998.","DOI":"10.3109\/13550289809114225"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Matsuzaki T, Nakagawa M, Nagai M, et al. HTLV-I-associated myelopathy (HAM)\/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations. J Neurovirol 6: 544-548, 2000.","DOI":"10.3109\/13550280009091955"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kuroda Y, Sugihara H. Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations. J Neurol Sci Dec 106: 199-205, 1991.","DOI":"10.1016\/0022-510X(91)90258-9"},{"key":"6","unstructured":"6. Arimura K, Nakagawa M, Izumo S, et al. HTLV-1-associated myelopathy (HAM) presenting with ALS-like feature. In: HTLV-1 and the Nervous System. Roman G, Vernant JC, Osame M, Eds. Alan R. Liss, New York, 1989: 367-370."},{"key":"7","unstructured":"7. Vernant JC, Buisson G, Bellance R, François MA, Madkaud O, Zavaro O. Pseudo-amyotrophic lateral sclerosis, peripheral neuropathy and chronic polyradiculoneuritis in patients with HTLV-1-assosiated paraplegias. In: HTLV-1 and the Nervous System. Roman G, Vernant JC, Osame M, Eds. Alan R. Liss, New York, 1989: 361-365."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Evans BK, Gore I, Harrell LE, Arnold T, Oh SJ. HTLV-I-associated myelopathy and polymyositis in a US native. Neurology 39: 1572-1575, 1989.","DOI":"10.1212\/WNL.39.12.1572"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Silva MT, Leite AC, Alamy AH, Chimelli L, Andrada-Serpa MJ, Araújo AQ. ALS syndrome in HTLV-I infection. Neurology 65: 1332-1333, 2005.","DOI":"10.1212\/01.wnl.0000180962.47653.5e"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Iwasaki Y, Sawada K, Aiba I, et al. Widespread active inflammatory lesions in a case of HTLV-I-associated myelopathy lasting 29 years. Acta Neuropathol 108: 546-551, 2004.","DOI":"10.1007\/s00401-004-0924-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Souza A, Tanajura D, Toledo-Cornell C, Santos S, Carvalho EM. Immunopathogenesis and neurological manifestations associated to HTLV-I infection. Rev Soc Bras Med Trop 45: 545-552, 2012.","DOI":"10.1590\/S0037-86822012000500002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nagai M, Tsujii T, Iwaki H, Nishikawa N, Nomoto M. Cerebrospinal fluid neopterin, but not osteopontin, is a valuable biomarker for the treatment response in patients with HTLV-I-associated myelopathy. Intern Med 52: 2203-2208, 2013.","DOI":"10.2169\/internalmedicine.52.0869"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T06:59:18Z","timestamp":1566629958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/9\/54_54.3660\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.3660","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}